← back to search

Dan Douer

University of Southern California · US
Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, and Childhood Cancer Survivors' Quality of Life.
h-index
48
citations
11,545
works
287
NIH funding
primary concept
email

Recent publications

Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia
Blood Reviews 2021cited by 41position: firstdoi
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials
Blood Advances 2021cited by 38position: middledoi
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
British Journal of Haematology 2020cited by 17position: middledoi
Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
JAMA Oncology 2018cited by 166position: middledoi
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
Blood Advances 2018cited by 159position: middledoi
Treatment of young adults with Philadelphia‐negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper‐CVAD vs. pediatric‐inspired regimens
American Journal of Hematology 2018cited by 50position: middledoi
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Blood 2017cited by 124position: middledoi
A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
Cancer Medicine 2016cited by 77position: middledoi
Acute Lymphoblastic Leukemia, Version 2.2015
Journal of the National Comprehensive Cancer Network 2015cited by 245position: middledoi
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death
Leukemia Research 2013cited by 133position: middledoi
Acute Lymphoblastic Leukemia
Journal of the National Comprehensive Cancer Network 2012cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Martin S. Tallman · Midwestern University6 papers (2013–2021)Selina M. Luger · Dana-Farber Cancer Institute4 papers (2018–2021)Wendy Stock · Leukemia Research Foundation3 papers (2018–2021)Jae H. Park · Memorial Sloan Kettering Cancer Center3 papers (2013–2018)Jacob M. Rowe · Technion – Israel Institute of Technology3 papers (2013–2020)Mark R. Litzow · Mayo Clinic3 papers (2017–2021)Peter H. Wiernik · Kids' Brain Tumor Cure Foundation3 papers (2017–2021)Lori Muffly · Stanford Health Care2 papers (2018–2018)Brandon Hayes‐Lattin · OHSU Knight Cancer Institute2 papers (2018–2018)Bijal Shah · Stanford University2 papers (2018–2018) · 2 papers (2018–2018)Mark A. Lewis · Huntsman Cancer Institute2 papers (2018–2018)Rebecca H. Johnson · Seattle Children's Hospital2 papers (2018–2018)Hillard M. Lazarus · Case Western Reserve University2 papers (2020–2021)Todd Rosenblat · NewYork–Presbyterian Hospital2 papers (2013–2018)Nita L. Seibel · National Cancer Institute2 papers (2018–2018)Archie Bleyer · Oregon Health & Science University2 papers (2018–2018)Joseph G. Jurcic · Columbia University Irving Medical Center2 papers (2013–2018)Eytan M. Stein · The University of Texas MD Anderson Cancer Center2 papers (2013–2017)Jerry J. Jaboin · Oklahoma State University Oklahoma City2 papers (2018–2018)